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Abstract
Background: Unusual presentation of breast lymphoma with signs and symptoms suggestive of inflammatory
breast cancer.
Discussion: Lymphoma of the breast is uncommon whether it is primary or secondary. Most breast lymphomas
are of B cell origin. The most frequent mode of presentation is a painless breast mass. The clinical presentation of
localized left breast erythema and edema with an associated left breast mass is common for an inflammatory
breast cancer but highly unusual for lymphoma of the breast.
Conclusion: In patients with a left breast mass associated with erythema and edema, the differential diagnosis
should include breast lymphoma in addition.
Background
Lymphoma of the breast is uncommon and it consti-
tutes 0.04% to 0.5% of malignant breast neoplasms
[1]. Treatment can include surgery, chemotherapy,
and radiation. We report a patient who presented
with physical exam mimicking an inflammatory breast
cancer however had secondary involvement of the
breast by regional lymphoma. The clinical presenta-
tion was highly unusual which made the diagnosis a
challenge.
Case Presentation
The patient is an 89 year old Caucasian lady, with mul-
tiple medical co-morbidities, who presented to the
Emergency Department with decreased functional ability
and a history of left breast erythema and edema over
one week duration. On exam there was a left breast
mass at 12:00, central lesion surrounding the areola, 3
cm × 3 cm, hard, non-tender and with indistinct bor-
ders. There was extensive erythema and edema encom-
passing the upper outer quadrant of the left breast
extending into the axilla (Figure 1). The left axilla had
palpable, matted lymph nodes, with a superficial 1.5 cm
protruding node. Right breast was within normal limits.
Examination of the right axilla and supra-clavicular
regions revealed fullness. No other cervical or inguinal
lymphadenopathy and no organomegaly was noted on
abdominal exam.
Initial laboratory work up showed a normal white
blood count of 4,500 with normal differential. A CAT
scan of the chest was done which revealed diffuse left
breast edema with two large left breast lesions, the lar-
gest measuring 7.8 × 7.2 cm in size, (Figure 2) and left
axillary adenopathy. It also showed adenopathy involving
the right axilla and right supra-clavicular regions. CAT
scans of the brain, abdomen and pelvis were normal.
She was admitted to the medicine service and treated
with intravenous antibiotics based on clinical evidence
of left breast erythema/cellulitis.
Breast surgery consultation was obtained. Upon
further questioning, the patient admitted to noticing a
left axillary mass six months ago, however did not seek
any medical attention. She denied constitutional symp-
toms including fever, chills, night sweats and weight
loss. The patient’s last mammogram was ten years ago.
The patient also has history of dementia.
The differential diagnosis included lymphoma of the
breast as well as inflammatory breast cancer. A diagnos-
tic ultrasound of the left breast was then performed.
Ultrasound revealed an ill-defined, retro-areolar, hypoe-
choic, heterogeneous lesion corresponding to the mass
on physical exam and to the larger mass seen on the
CAT scan of the chest (Figure 3). The patient
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core biopsy. Pathology was consistent with diffuse large
B cell lymphoma (Figures 4 and 5). She underwent
further care with the oncology team.
Discussion
Lymphoma of the breast is rare either as a primary or a
secondary neoplasm. Most breast lymphomas are of B
Figure 1 Image of the extensive erythema and edema. Image of
the extensive erythema and edema of the left breast upper outer
quadrant extending into the left axilla.
Figure 4 The slide demonstrates H&E stain of the core biopsy tissue.
The slide demonstrates H&E stain of thec o r eb i o p s yt i s s u e consistent with
a diffuse large B cell lymphoma. The arrow points to a B cell.
Figure 3 An ultrasound image of the left breast. An ultrasound
image of the left breast, retro-areolar location, which reveals an ill-
defined, hypo-echoic, heterogenous mass corresponding to the
palpable mass on physical exam and the larger mass on the CAT
scan of the chest.
Figure 2 A CAT scan of the chest. A CAT scan of the chest
demonstrating a large breast mass measuring 7.8 × 7.2 cm in size
with associated left breast edema.
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diffuse large B cell lymphoma [2].
In the present case, the patient’s initial presentation
was with a left axillary mass followed by the left breast
erythema and edema and admission to the hospital. On
imaging, the tumor was limited to the left breast, left
axilla, right axilla, and right supra-clavicular regions, not
involving lymphatic chains in other basin. The lym-
phoma most likely originated in the left axillary lymph
n o d ea n dt h e ni n v o l v e dt h el e f tb r e a s ta se v i d e n c e db y
t h el e f tb r e a s tm a s so ne x a ma n dC A Ts c a nf i n d i n g s .
Hence we hypothesize that this is a secondary involve-
ment of the breast since there is involvement of the
contra-lateral (right) axilla and supra-clavicular regions
as well.
Recent literature shows that the incidence of primary
lymphoma of the breast might be increasing [3,4]. Primary
lymphoma of the breast is defined as the tumor localized
to the breast with or without ipsilateral axillary lymph
node metastases. In 50% of cases of primary lymphoma,
the ipsilateral axillary lymph nodes are involved [5,6].
The presentation of this patient with left breast mass,
erythema and edema (Figure 1) is unusual and it does
complicate the clinical diagnosis. Most common symp-
tom of breast lymphoma is a painless breast mass, most
frequently in the upper outer quadrants [5]. Skin retrac-
tion, erythema, peau d’ orange appearance, and nipple
discharge are uncommon in lymphomas [1-6].
Distinct mammographic or sonographic features have
not been described in the literature for breast lymphoma
to differentiate it from breast carcinoma or benign
breast entities. Imaging with an ultrasound in the pre-
sent case did not aid in the differential diagnosis of this
lesion. The CAT scan of the chest in this case showed
lymph node enlargement on the right (contralateral)
side which was the key in considering lymphoma in the
differential diagnosis of the left breast mass accompa-
nied with erythema and edema which was clinically
mimicking inflammatory breast cancer.
The definitive diagnosis should be made with a core
biopsy and will allow for therapeutic planning. At pre-
sent, the treatment of breast lymphoma, whether pri-
mary or secondary, should be with systemic
chemotherapy [7,8]. The role of surgery is minimal
since the tumors are highly sensitive both to chemother-
apy and radiation therapy [9-11]. Ryan et al reported
statistically significant poor cause-specific survival for
patients who underwent mastectomy [12]. Local radio-
therapy to involved sites is used to prevent loco-regional
recurrence [10-12]. This delivery of radiation therapy
alone has been found by Ryan et al to improve overall
survival [12]. Kim et al reported that a short course of
chemotherapy followed by local radiation therapy was a
safe approach for stage IAE disease [11]. For stage IIAE
disease, combination of full course of chemotherapy and
local radiation therapy has to be considered [11,12]. Sur-
vival outcomes were studied in the International Lym-
phoma Study Group and statistically significant benefit
was shown resulting from the addition of radiation ther-
apy to systemic chemotherapy [12].
The Extra Nodal Lymphoma Study Group also did note
that young age and stage IIE disease were associated with
poor prognosis [12]. Prognosis of patients with breast
lymphoma can range from 26 and 66% for 5 year survival
rates [13-18]. Diffuse large B cell type has worse prog-
nosis than other histologic subtypes and has significant
risk of contralateral breast involvement [13-18]. For sec-
ondary lymphoma involving the breast, the prognosis is
dependent on the staging of the primary [13-18].
Conclusions
Lymphoma of the breast is a very rare entity. This case
highlights the atypical presentation of lymphoma
mimicking an inflammatory breast cancer. Core biopsy
of the breast lesion will aid in resolving the diagnostic
dilemma and tailor the subsequent management.
Consent
Written informed consent was obtained from the
patient’s daughter, health care proxy, for publication of
this case report and accompanying images since the
patient lacked capacity due to dementia. A copy of the
written informed consent is available for review by the
Editor-in-Chief of this journal.
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Figure 5 Immunostain for CD20.T h i ss l i d es h o w st h a tt h e
immunostain for CD20, a B-cell marker, is positive.
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